¡GoConqr estrena diseño! Cuéntanos qué te parece.

Mapa mental

Respiratory Drugs

Samara Watts Inglés 5,0Valoración media 5,0 de 5 (1 valoración)

Contenido del mapa

Respiratory Drugs

  1. Bronchodilators

    • B2 adrenergic agonists
      • Short acting
        • Salbutamol, terbutaline
          • used for actue asthma
      • Long acting
        • eformoterol, salmeterol
          • used as a symptom controller
      • MOA: Stimulate B2 adrenergic receptors on the bronchial smooth muscles and stimulates sympathetic nervous system response - causing bronchodilation.
        • Adverse effects: tremors, tachycardia, headache, increased blood glucose levels,
    • Antimuscarinics
      • Short acting
        • Ipratropium
      • Long acting
        • tiotropium, glycopyrronium
      • Theraputic action: bronchodilation, decreased mucous secretion action
        • MOA: block muscarinic receptors and inhibit the parasympathetic nervous system
          • Adverse reactions: dry mouth/throat irritation, blurred vision.
    • Methylxanthines
      • Theophylline, aminophylline
        • Theraputic action: increased cellular activity and bronchodilation
          • MOA: inhibits the enzyme that degrades cAMP
            • Adverse reactions: insomnia, anxiety, tremors, tachycardia, nausea
  2. Preventer drug

    • Leukotriene receptor antagonists
      • Montelukast
        • Theraputic Action: mediate inflammatory reactions
          • MOA: blocks action of inflammation mediators
            • Adverse effects: headache, GI upset, thirst
    • Mast cell stabilisers
      • Sodium cromoglycale
        • Theraputic action: preventer group
          • MOA: prevents release of inflammatory mediators from mast cells
            • Adverse effects: Throat irritation, nausea
    • Steriods
      • Steroidal Anti-iinflammatory
        • Systemic corticosteriods
          • Prednisone, Methylprednisolone
        • Inhaled corticosteriods
          • Beclometasone, Fluticasone
        • Theraputic Action: bronchoconstriction and inflammation decreation
          • MOA: inhibits rupture of mast cells, decreases inflammatory mediators, suppresses antibody production and immune cells.
            • Adverse reactions: Fluid and electrolyte imbalance, immunosuppressence
      • Combined formulations
        • Seretide & Symbicort

Información

Descripción
Pharmacology 214.202 Massey university NZ
Creado por
Samara Watts · nov 2017
Actualizado
29 nov 2017
Visitas
75
Valoración
Valoración media 5,0 de 5 (1 valoración)

Escríbenos

¿Sobre qué es tu mensaje?

¿Qué te parece el nuevo diseño?

¿Te gusta?